pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison With pN0 and pN1a in the Modern Era.
Dosani M, Hamilton SN, Gondara L, Speers C, Diocee RM, Nichol A, Lohrisch C, Truong P.
Dosani M, et al.
Int J Radiat Oncol Biol Phys. 2022 Jul 15;113(4):805-815. doi: 10.1016/j.ijrobp.2022.03.029. Epub 2022 Apr 3.
Int J Radiat Oncol Biol Phys. 2022.
PMID: 35385784
RESULTS: Median follow-up was 9.3 years. In patients with pN0 (n = 7492), pN0(i+) (n = 305), pN1mi (n = 619), and pN1a (n = 1855) disease, LRRT was used in 1.1%, 24.3%, 45.7%, and 71.1%, respectively. ...
RESULTS: Median follow-up was 9.3 years. In patients with pN0 (n = 7492), pN0(i+) (n = 305), pN1mi (n = 619), and pN1a …